These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 2254046)
1. Long term cardiopulmonary bypass without systemic heparinization. von Segesser K; Turina M Int J Artif Organs; 1990 Oct; 13(10):687-91. PubMed ID: 2254046 [TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators. von Segesser LK; Turina M J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320 [TBL] [Abstract][Full Text] [Related]
3. [Cardiopulmonary bypass over 24 hours without systemic anticoagulation: new horizons?]. von Segesser LK; Turina M Helv Chir Acta; 1990 Oct; 57(2):389-93. PubMed ID: 2074206 [TBL] [Abstract][Full Text] [Related]
4. Superior hemodynamics in left heart bypass without systemic heparinization. von Segesser LK; Weiss BM; Gallino A; Leskosek B; Redha F; von Felten A; Turina M Eur J Cardiothorac Surg; 1990; 4(7):384-8; discussion 389. PubMed ID: 2397131 [TBL] [Abstract][Full Text] [Related]
5. Reduction and elimination of systemic heparinization during cardiopulmonary bypass. von Segesser LK; Weiss BM; Garcia E; von Felten A; Turina MI J Thorac Cardiovasc Surg; 1992 Apr; 103(4):790-8; discussion 798-9. PubMed ID: 1548923 [TBL] [Abstract][Full Text] [Related]
6. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
7. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. von Segesser LK; Weiss BM; Garcia E; Gallino A; Turina M Eur J Cardiothorac Surg; 1990; 4(12):639-43. PubMed ID: 2288743 [TBL] [Abstract][Full Text] [Related]
8. Experimental evaluation of heparin-coated cardiopulmonary bypass equipment with low systemic heparinization and high-dose aprotinin. von Segesser LK; Weiss BM; Pasic M; Leskosek B; von Felten A; Pei P; Turina M Thorac Cardiovasc Surg; 1991 Oct; 39(5):251-6. PubMed ID: 1723816 [TBL] [Abstract][Full Text] [Related]
9. Performance characteristics of centrifugal pumps with heparin surface coating. von Segesser LK; Lachat M; Gallino A; Weiss BM; Leskosek B; Garcia E; Hänseler E; von Felten A; Turina M Thorac Cardiovasc Surg; 1990 Aug; 38(4):224-8. PubMed ID: 2237882 [TBL] [Abstract][Full Text] [Related]
10. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support. von Segesser LK Ann Thorac Surg; 1996 Jan; 61(1):330-5; discussion 340-1. PubMed ID: 8561600 [TBL] [Abstract][Full Text] [Related]
11. Clinical application of heparin-coated perfusion equipment with special emphasis on patients refusing homologous transfusions. von Segesser LK; Weiss BM; Garcia E; Turina MI Perfusion; 1991; 6(3):227-33. PubMed ID: 10171161 [TBL] [Abstract][Full Text] [Related]
12. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report. von Segesser LK; Garcia E; Turina MI Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221 [TBL] [Abstract][Full Text] [Related]
19. Risk and benefit of low systemic heparinization during open heart operations. von Segesser LK; Weiss BM; Pasic M; Garcia E; Turina MI Ann Thorac Surg; 1994 Aug; 58(2):391-7; discussion 398. PubMed ID: 8067837 [TBL] [Abstract][Full Text] [Related]